Business context and reporting period
Nova Ltd. filed an annual Form 20-F for the fiscal year ended December 31, 2023; this is not a standalone fourth-quarter report. Nova sells metrology and process-control systems and related services to semiconductor manufacturers. Financial statements are prepared under U.S. GAAP and presented in U.S. dollars.
Financial performance and liquidity
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Revenue | $517.9 million | $570.7 million | Down 9% |
| Product revenue | $405.0 million | $464.2 million | Down 13% |
| Service revenue | $112.9 million | $106.6 million | Up 6% |
| Gross profit / margin | $293.2 million / 56.6% | $317.0 million / 55.5% | Margin improved |
| Operating income / margin | $132.3 million / 25.5% | $149.9 million / 26.3% | Income down 12% |
| Net income / margin | $136.3 million / 26.3% | $140.2 million / 24.6% | Income down 3% |
| Basic / diluted EPS | $4.73 / $4.28 | $4.89 / $4.43 | Both lower |
| Operating cash flow | $123.5 million | $119.5 million | Up 3% |
Net financial income rose to $22.4 million from $8.5 million, mainly reflecting higher interest income. The effective tax rate was 11.9%, compared with 11.7%.
At year-end, cash, deposits, and marketable securities totaled $641 million, including $407.6 million of marketable securities. Working capital was approximately $387 million, down from $479 million, largely because the convertible notes were classified as current. The company reported approximately $444 million of cash reserves net of convertible notes. Operating cash flow funded investment spending; cash flow from investing activities was negative $125.3 million. Gross capital expenditure, including items moved from inventory to capital and new ERP investment, was approximately $25 million.
The $200 million principal amount of 0% convertible senior notes is due October 15, 2025. Their net carrying value was $197.7 million at year-end and they were classified as current because a conversion condition had been met. The initial conversion price is approximately $74.60 per share. The company said available cash should fund planned activities for at least 12 months and expects 2024 gross capital spending of approximately $35 million.
Material changes versus the prior comparable period
- Revenue fell 9%, following 37% growth in 2022. Lower wafer-fab equipment investment and capacity expansion reduced product sales; service growth reflected a larger installed base.
- Product gross margin improved to 60% from 59%, and service gross margin to 46% from 41%, attributed to product/customer mix and cost restraint. Overall gross margin rose to 56.6% from 55.5%.
- Operating expenses declined to $160.9 million from $167.0 million. R&D was $88.0 million, or 17% of revenue, versus $90.5 million, or 16%; G&A declined mainly because 2022 included ancosys acquisition costs.
- Inventory increased to $138.2 million from $116.6 million, which management linked to anticipated first-half 2024 business levels and new-product proliferation. Inventory write-downs were $8.7 million, versus $6.4 million.
- Cash, deposits, and marketable securities increased to $641 million from $529 million, while operating cash flow rose to $123.5 million from $119.5 million.
Outlook, risks, contingencies, and unusual items
Management’s 2024 priorities include new product development, expanding materials, chemical, and dimensional metrology offerings, advanced packaging, and continued investment in facilities and ERP/CRM systems. It reiterated a strategic goal of reaching $1 billion in revenue through organic and inorganic growth, without specifying a timeline. The filing cites Gartner forecasts of 18% semiconductor revenue growth and a 4% decline in wafer-fab equipment spending in 2024, after declines of 11% and 8%, respectively, in 2023.
Key risks include semiconductor-market cyclicality, customer and product concentration, export controls affecting China, geopolitical and trade disruption, and the Israel-Hamas war’s potential effects on employees, operations, suppliers, shipping, and sales. The filing also highlights cybersecurity and ERP implementation risk, foreign-exchange exposure, dependence on limited suppliers and manufacturing sites, and potential dilution or cash-settlement requirements under the 2025 notes. Five largest customers represented 52% of 2023 revenue; China accounted for 36% of revenue. The company reported no material legal proceedings or material claims requiring accrual at year-end, and does not expect to pay cash dividends for at least several years.
Nova disclosed that its 2022 diluted EPS was voluntarily corrected for an immaterial calculation error, from $4.40 previously reported to $4.43 as adjusted. The filing indicates the financial statements reflect a correction of an error; investors should review the related disclosure and any implications. Auditors issued unqualified opinions on the financial statements and internal controls; management and the auditor concluded internal control over financial reporting was effective as of December 31, 2023.
Important facts for investors to verify
- Track product demand and customer concentration, particularly China exposure and the timing of semiconductor capital-spending recovery.
- Review the $200 million notes’ conversion, repurchase, and October 2025 maturity terms, including available liquidity for any cash settlement.
- Assess inventory growth, the $8.7 million write-down, and management’s demand assumptions; inventory valuation was the auditor’s critical audit matter.
- Monitor execution of the ERP transition, planned $35 million 2024 capital spending, and the longer-term $1 billion revenue objective.
- Confirm the implications of the disclosed immaterial 2022 diluted-EPS correction and reconcile share-repurchase disclosures if relying on cumulative repurchase totals.